Valuation: Aprogen Medicines Inc.

Market Cap 48.81B 32.31M 28.34M 26.16M 24.18M 45.82M 3.09B 46.74M 315M 122M 1.51B 121M 119M 5.26B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 186B 123M 108M 99.65M 92.09M 175M 11.78B 178M 1.2B 465M 5.77B 462M 452M 20.02B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
79.55%
Yield 2024 *
-
Yield 2025 -
05-28 Aprogen Medicines Inc. announced that it has received KRW 10 billion in funding from N2Tech Co.,Ltd CI
05-20 APTN Inc. announced that it has received KRW 122.600000101 billion in funding from Aprogen, Inc., Aprogen Medicines Inc., Aprogen Pharma Inc. and other investors. CI
05-15 Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-08 Aprogen Medicines Inc. announced that it has received KRW 12 billion in funding from APTOCROM Inc. CI
04-27 Aprogen Medicines Inc. announced that it expects to receive KRW 12 billion in funding from APTOCROM Inc. CI
04-16 Aprogen Medicines Inc. announced that it has received KRW 2.00000351 billion in funding from G-Baise Inc. CI
04-01 Aprogen Medicines Inc. announced that it expects to receive KRW 2.00000351 billion in funding from G-Baise Inc. CI
03-23 Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
11-14 Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-14 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-21 Aprogen Medicines Inc. agreed to acquire an additional 20.06% stake in AP Healthcare Inc. from Aprogen Biologics Inc. for KRW 58.4 billion. CI
25-05-15 Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-13 Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
1 day-3.93%
1 week-7.20%
Current month-7.20%
1 month-27.61%
3 months-44.76%
6 months-78.28%
Current year-77.81%
1 week 2,275
Extreme 2275
2,630
1 month 2,275
Extreme 2275
3,480
Current year 2,275
Extreme 2275
11,880
1 year 2,275
Extreme 2275
14,070
3 years 2,275
Extreme 2275
47,775
5 years 2,275
Extreme 2275
110,250
10 years 2,275
Extreme 2275
875,250
Manager TitleAgeSince
Chief Executive Officer 63 2017-12-26
Comptroller/Controller/Auditor 69 2018-03-27
Director TitleAgeSince
Director/Board Member 63 2022-11-28
Director/Board Member 64 2022-07-17
Director/Board Member 62 2023-10-12
Date Insider Type Main position Quantity % Market Cap.
25-01-16Others 7,673 0.0025%
24-01-18Free 101,429 0.0383%
24-01-18Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-3.93%-7.20%-76.64%-86.30% 33.54M
-1.88%-14.80%+434.92%+389.10% 19.75B
-2.58%-3.88%+13.05%+25.85% 14.02B
-6.34%-6.49%-30.73%+30.29% 5.72B
-2.62%-1.50%+223.74%+109.25% 3.82B
-3.50%-24.09%+72.30%+35.60% 3.45B
-6.00%-26.04%+201.34%+243.60% 2.15B
-6.31%-18.80%+21.62%-10.17% 1.35B
-0.57%-0.99%+6.73%+36.71% 924M
-5.16%-3.88%-9.41%+32.26% 855M
Average -3.89%-5.85%+85.69%+80.62% 5.21B
Weighted average by Cap. -3.05%-1.68%+195.10%+179.18%

Financials

2024 2025
Net sales 150B 99.37M 87.16M 80.46M 74.36M 141M 9.51B 144M 967M 376M 4.66B 373M 365M 16.16B 118B 78.09M 68.5M 63.24M 58.44M 111M 7.48B 113M 760M 295M 3.66B 293M 287M 12.7B
Net income -58.08B -38.45M -33.72M -31.13M -28.77M -54.53M -3.68B -55.62M -374M -145M -1.8B -144M -141M -6.25B -70.2B -46.47M -40.76M -37.63M -34.77M -65.91M -4.45B -67.23M -452M -176M -2.18B -175M -171M -7.56B
Net Debt 70.04B 46.36M 40.67M 37.54M 34.69M 65.76M 4.44B 67.07M 451M 175M 2.17B 174M 170M 7.54B 137B 90.75M 79.6M 73.49M 67.91M 129M 8.69B 131M 883M 343M 4.25B 341M 333M 14.76B
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
253
Date Price Change Volume
26-07-07 2,320.00 -3.93% 198,032
26-07-07 ₩2,415.00 -3.01% 205,515
26-07-06 ₩2,490.00 -0.80% 105,807
26-07-03 ₩2,510.00 +1.83% 96,259
26-07-02 ₩2,465.00 -3.33% 176,606
  1. Stock Market
  2. Stocks
  3. A007460 Stock